|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,217.00 JPY | -0.25% |
|
-3.45% | +5.58% |
| Dec. 09 | Texas Medical Center Expands Global Impact with Launch of TMC Japan BioBridge and JACT Program | CI |
| Nov. 12 | Mitsui Fudosan Co., Ltd., H1 2025 Earnings Call, Nov 12, 2024 |
| Capitalization | 3,399B 22.35B 21.28B 19.72B 17.54B 31.66B 1,897B 35.09B 246B 90.64B 779B 83.93B 82.11B | P/E ratio 2025 * |
14.1x | P/E ratio 2026 * | 12.9x |
|---|---|---|---|---|---|
| Enterprise value | 7,632B 50.19B 47.77B 44.27B 39.38B 71.08B 4,259B 78.78B 551B 204B 1,749B 188B 184B | EV / Sales 2025 * |
2.97x | EV / Sales 2026 * | 2.93x |
| Free-Float |
-
| Yield 2025 * |
2.47% | Yield 2026 * | 2.75% |
More valuation ratios
* Estimated data
More news
Last Transcript: Mitsui Fudosan Co., Ltd.
More press releases
More news
| 1 day | +0.29% | ||
| 1 week | -4.26% | ||
| Current month | -2.43% | ||
| 1 month | -7.13% | ||
| 3 months | -13.93% | ||
| 6 months | -19.24% | ||
| Current year | +6.15% |
1 week
1 220.00
1 278.00
1 month
1 220.001 354.00
Current year
1 132.671 709.50
1 year
1 112.001 709.50
3 years
737.001 709.50
5 years
512.671 709.50
10 years
512.671 709.50
| Director | Title | Age | Since |
|---|---|---|---|
Takashi Ueda
CEO | Chief Executive Officer | 63 | - |
Takayuki Miki
PRN | Corporate Officer/Principal | 64 | 2017-03-31 |
Wataru Hamamoto
PRN | Corporate Officer/Principal | 63 | 2017-03-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Masanobu Komoda
CHM | Chairman | 70 | - |
Yasuo Onozawa
BRD | Director/Board Member | 65 | 2016-05-31 |
Takashi Yamamoto
BRD | Director/Board Member | 65 | 2017-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 22.20% | 16 M€ | +9.94% | ||
| 2.16% | 4,301 M€ | +3.88% | ||
| 1.84% | 311 M€ | +8.42% | ||
| 1.42% | 136 M€ | +19.98% | ||
| 1.23% | 168 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.20% | -4.26% | +4.42% | +53.74% | 22.77B | ||
| +0.77% | +1.95% | +1.68% | -18.90% | 29.04B | ||
| +0.66% | +2.27% | +33.62% | +117.86% | 25.17B | ||
| -2.73% | -3.14% | +25.34% | +89.16% | 22.88B | ||
| -2.23% | +3.66% | -6.23% | -31.14% | 22.61B | ||
| -2.68% | +2.22% | +6.64% | -29.49% | 19.99B | ||
| -2.22% | +14.29% | +274.47% | +1,642.57% | 19.16B | ||
| +0.09% | -0.98% | +9.89% | +35.66% | 17.56B | ||
| +1.82% | +8.69% | +52.73% | +95.03% | 16.17B | ||
| +1.62% | -2.05% | +2.66% | -34.19% | 16.12B | ||
| Average | -0.45% | +3.45% | +40.52% | +192.03% | 21.15B | |
| Weighted average by Cap. | -0.49% | +3.22% | +37.33% | +177.16% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2,567B 16.88B 16.07B 14.89B 13.24B 23.91B 1,433B 26.49B 185B 68.44B 588B 63.37B 62.01B | 2,616B 17.2B 16.38B 15.18B 13.5B 24.37B 1,460B 27B 189B 69.76B 600B 64.59B 63.2B |
| Net income | 241B 1.58B 1.51B 1.4B 1.24B 2.24B 134B 2.49B 17.39B 6.42B 55.18B 5.95B 5.82B | 262B 1.72B 1.64B 1.52B 1.35B 2.44B 146B 2.7B 18.92B 6.99B 60.04B 6.47B 6.33B |
| Net Debt | 4,233B 27.84B 26.5B 24.55B 21.84B 39.42B 2,362B 43.69B 306B 113B 970B 105B 102B | 4,270B 28.08B 26.73B 24.77B 22.03B 39.77B 2,383B 44.08B 308B 114B 979B 105B 103B |
More financial data
* Estimated data
Employees
25,593
Calendar
2025-02-06
- Q3 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-10 | 1,217.00 ¥ | -0.25% | 2,733,700 |
| 24-12-10 | 1,220.00 ¥ | -1.17% | 9,294,900 |
| 24-12-09 | 1,234.50 ¥ | -0.28% | 6,460,400 |
| 24-12-06 | 1,238.00 ¥ | -1.51% | 9,131,400 |
| 24-12-05 | 1,257.00 ¥ | -0.28% | 11,851,200 |
Delayed Quote Japan Exchange, December 10, 2024 at 07:11 pm EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,220.00JPY
Average target price
1,718.18JPY
Spread / Average Target
+40.83%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 8801 Stock